News & Events

In this section

KnowledgeScan Target Safety Assessment Showcasing at Society of Toxicology Annual Meeting

Instem to Present Novel Approach for Drug Safety Assessment

CONSHOHOCKEN, PA – March 3, 2016 - -Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that it will showcasing its KnowledgeScan™ Target Safety Assessment Service at this year’s Society of Toxicology’s 55th Annual Meeting taking place in New Orleans.

Developed and optimized by experienced toxicologists and bioinformaticians, Instem’s KnowledgeScan™ Target Safety Assessment Service ensures optimal toxicological interpretation of target genetics and biology using powerful information technology and transparent, systematic and comprehensive analytical workflows. 

Showcase Events

Monday March 14th – 16th
Members of the international team will be at booth #737 to talk more about the benefits of deploying KnowledgeScan™ as an effective alternative, or supplement, to your in-house target safety assessment capabilities. 

Tuesday, March 15th  4:30pm – 5:30pm
Room 213, 2nd floor
Join Instem and our special guest, Dr. James Sidaway, Director at Phenotox Ltd., for an interactive and informative group session that will review how KnowledgeScan™ provides an optimal assessment of toxicity risks relating to target or therapeutic modality using automated data mining and expert review.”
Appetizers and drinks will be served (free entry).

Thursday, March 17th  9:30am – 12:45pm
Great Hall A – Late Breaking Poster Session 2
Please stop by to review and discuss the following poster presentations. Instem staff and a client co-author will be on-hand:

A systematic comparison of genetic intervention and antibody studies for the immune check point inhibitors supports a strategy for predicting novel target-mediated toxicities - Poster board #3668/P360

A systematic assessment of human druggable target genes identifies absent orthologues in mouse
and rat - Poster board #3667/P359

“Following years of investment and development, we are very encouraged by the attention that KnowledgeScan™ is receiving,” comments Gordon Baxter, Chief Scientific Officer at Instem. “The response to this unique technology-driven approach and feedback from our clients has been excellent. We see this as a real research accelerator and something that will help reveal new insight beyond what clients can do manually much more quickly and efficiently.”

For more than a decade Instem has helped its pharmaceutical customers develop safer, more effective drugs with its blend of specialist software, knowledge bases and vocabulary products, backed up by a team of experienced scientific and IT professionals. Known for supplying fast, practical and cost-effective solutions, Instem has enhanced its data mining and analysis platforms making KnowledgeScan™ one of the most powerful solutions available today.

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in Japan and India.

Press Contacts:

Gary Mitchell (US HQ)
Tel: 610-941-0990

Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600